Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Intramuscular interferon beta-1a is effective in Japanese patients with relapsing-remitting multiple sclerosis: a pre-treatment versus treatment comparison study of gadolinium-enhanced MRI brain lesions.
Clinical Assessment of Orofacial Manifestations in 500 Patients With Multiple Sclerosis.
Added benefit of fampridine is not proven
White matter volume is decreased in the brain of patients with neuromyelitis optica.
Long-term efficacy, tolerability and retention rate of azathioprine in 103 aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder patients: a multicentre retrospective observational study from the UK.
Multiple sclerosis and bipolar disorders: The burden of comorbidity and its consequences on quality of life.
Psychotherapeutic and psychosocial interventions for managing stress in multiple sclerosis: the contribution of mindfulness-based interventions.
T cell vaccination in multiple sclerosis: results of a preliminary study.
Alemtuzumab 3-year data show durable effect on MS disability
Contributions of vitamin D response elements and HLA promoters to multiple sclerosis risk.
Neurorehabilitation for other neurologic disorders.
Dual role of Response gene to complement-32 in multiple sclerosis.
Social cognition in pediatric-onset multiple sclerosis (MS).
Reliability of a cognitive endpoint for use in a multiple sclerosis pharmaceutical trial.
Strategies for myelin regeneration: lessons learned from development.
Mu opioid receptor activation modulates Toll like receptor 4 in murine macrophages.
Plasma chemerin levels in patients with multiple sclerosis.
A pilot randomised controlled trial of an Internet-based cognitive behavioural therapy self-management programme (MS Invigor8) for multiple sclerosis fatigue.
Epstein-Barr virus latent membrane protein 2A exacerbates experimental autoimmune encephalomyelitis and enhances antigen presentation function.
Spinal Cord Atrophy and Early Motor Recovery following Transverse Myelitis in Pediatric Patients.
A practical guide to the treatment of neuromyelitis optica.
A unifying multiple sclerosis etiology linking virus infection, sunlight, and vitamin D, through viral interleukin-10.
Remote effects of intermittent theta burst stimulation of the human pharyngeal motor system.
Fingolimod (FTY720) inhibits neuroinflammation and attenuates spontaneous convulsions in lithium-pilocarpine induced status epilepticus in rat model.
The genetics of multiple sclerosis.
Pages
« first
‹ previous
…
188
189
190
191
192
193
194
195
196
…
next ›
last »